PORTLAND, Ore. — At OHSU's Knight Cancer Institute, researchers are focused on finding ways to detect cancer earlier and produce more targeted treatments for individual types of cancer.

Druker is still at OHSU, now as the CEO of the Knight Cancer Institute. With Gleevec, he found a way to give thousands of people a new lease on life. He joked with Dooris that he now tells ...

Researchers have created a new kind of nanoparticle that could make ultrasound-based cancer treatments more effective and safer, while also helping prevent tumors from coming back.

The director of Oregon Health & Science University’s $1 billion Knight Cancer Institute resigned this week after just one year on the job, leaving OHSU with yet another interim leader in a key role.

Dr. Brian Druker, the head of Oregon Health & Science University’s Knight Cancer Institute, has abruptly stepped down from his role. Druker, who served as the institute’s director for 17 years ...

OHSU has confirmed that the leader of the Knight Cancer Institute, Dr. Brian Druker, is resigning as CEO. The university said he will continue running his research lab and seeing patients.

a scientist with OHSU Knight Cancer Institute’s Cancer Early Detection Advanced Research Center (CEDAR). “Our goal with PAC-MANN is to give clinicians a tool that can detect the disease much ...

Dr. Shivaani Kummar is taking over the top job at the Knight Cancer Center from Dr. Brian Druker. How 'catastrophic' NIH cuts could derail cancer research in Oregon Opinion: Top scientists on how ...

Shivaani Kummar, MD, has been appointed interim chief executive of Portland-based Oregon Health and Science University’s Knight Cancer Institute. She will serve as interim chief until OHSU ...

PORTLAND, Ore. (KATU) — The CEO of OHSU’s Knight Cancer Institute is stepping down. On Tuesday, Dr. Brian Druker announced his resignation. Druker developed a revolutionary drug to treat cancer.